We are live on ! Find out more
PC

Pavadi Capital Portfolio holdings

AUM $81.2M
1-Year Est. Return 5.26%
This Fund
S&P 500
This Quarter Est. Return
+10.12%
1 Year Est. Return
+5.26%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$106M
AUM Growth
+$1.66M
Cap. Flow
-$5.18M
Cap. Flow %
-4.89%
Top 10 Hldgs %
63.05%
Holding
28
New
5
Increased
11
Reduced
2
Closed
10

Top Buys

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$6.1M
2
PDCO
Patterson Companies, Inc.
PDCO
+$5.97M
3
IART icon
Integra LifeSciences
IART
+$5.53M
4
LNTH icon
Lantheus
LNTH
+$5.03M
5
AVTR icon
Avantor
AVTR
+$4.36M

Top Sells

Rank Stock Value
1
AMN icon
AMN Healthcare
AMN
+$5.96M
2
UHS icon
Universal Health Services
UHS
+$4.28M
3
COR icon
Cencora
COR
+$4.27M
4
INMD icon
InMode
INMD
+$3.77M
5
MRVI icon
Maravai LifeSciences
MRVI
+$3.69M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MOH icon
1
Molina Healthcare
MOH
$10.2B
$9.36M 8.82%
28,349
+1,562
+6% +$531K
CNC icon
2
Centene
CNC
$30.7B
$8.4M 7.92%
102,419
+5,644
+6% +$461K
HCA icon
3
HCA Healthcare
HCA
$87.2B
$6.62M 6.24%
27,600
+4,805
+21% +$1.08M
DGX icon
4
Quest Diagnostics
DGX
$25.7B
$6.55M 6.18%
41,899
-191
-0.5% -$27.4K
HOLX
5
DELISTED
Hologic
HOLX
$6.14M 5.79%
82,117
+11,487
+16% +$818K
IART icon
6
Integra LifeSciences
IART
$1.29B
$6.09M 5.74%
+108,667
New +$5.53M
CAH icon
7
Cardinal Health
CAH
$53.9B
$6.07M 5.73%
79,028
-43,395
-35% -$3.3M
PDCO
8
DELISTED
Patterson Companies, Inc.
PDCO
$6.07M 5.72%
+216,412
New +$5.97M
MDT icon
9
Medtronic
MDT
$109B
$5.85M 5.51%
+75,273
New +$6.1M
CVS icon
10
CVS Health
CVS
$133B
$5.73M 5.4%
61,440
+13,899
+29% +$1.34M
HUM icon
11
Humana
HUM
$43.7B
$5.65M 5.33%
11,031
+1,070
+11% +$562K
CI icon
12
Cigna
CI
$73.8B
$5.44M 5.13%
16,414
+904
+6% +$286K
LH icon
13
Labcorp
LH
$25.4B
$5.25M 4.95%
25,954
+3,307
+15% +$646K
THC icon
14
Tenet Healthcare
THC
$20.5B
$4.96M 4.68%
101,727
+15,191
+18% +$702K
UNH icon
15
UnitedHealth
UNH
$376B
$4.78M 4.5%
9,009
+495
+6% +$262K
ELV icon
16
Elevance Health
ELV
$81.5B
$4.53M 4.27%
8,834
+488
+6% +$248K
AVTR icon
17
Avantor
AVTR
$9.32B
$4.45M 4.19%
+210,780
New +$4.36M
LNTH icon
18
Lantheus
LNTH
$6.49B
$4.15M 3.92%
+81,512
New +$5.03M
AMN icon
19
AMN Healthcare
AMN
$1.3B
– –
-56,268
Closed -$5.96M
COR icon
20
Cencora
COR
$60.6B
– –
-31,537
Closed -$4.27M
FLGT icon
21
Fulgent Genetics
FLGT
$470M
– –
-74,125
Closed -$2.83M
INMD icon
22
InMode
INMD
$870M
– –
-129,357
Closed -$3.77M
MD icon
23
Pediatrix Medical
MD
$2.18B
– –
-167,304
Closed -$2.76M
MRVI icon
24
Maravai LifeSciences
MRVI
$969M
– –
-144,569
Closed -$3.69M
QDEL icon
25
QuidelOrtho
QDEL
$1.14B
– –
-31,327
Closed -$2.24M
1
2

Similar funds

BAM
Broadmark Asset Management San Francisco, California $80.4M AUM 29.98% 1-Year Est. Return
TCM
Tegean Capital Management New York $82.1M AUM 12.91% 1-Year Est. Return
JAM
JLP Asset Management New York $84.2M AUM 10.86% 1-Year Est. Return
HH
HP Holding New York $84.5M AUM 4.73% 1-Year Est. Return
CPI
Canaan Partners IX Menlo Park, California $87.5M AUM
SLM
Snow Lake Management Menlo Park, California $90.7M AUM 72.65% 1-Year Est. Return
AFG
Alterity Financial Group Bangor, Maine $69.9M AUM 40.65% 1-Year Est. Return
TIMH
Tilt Investment Management Holdings New York $92.6M AUM 28.92% 1-Year Est. Return

Pavadi Capital's Q4 2022 Portfolio in Review

As of Q4 2022, Pavadi Capital held 28 positions worth $106M, up 1.6% from $104M the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Pavadi Capital withdrew a net $5.18M in Q4 2022, closing 10 positions and reducing 2 holdings. Its most notable exit was AMN Healthcare, an estimated $5.96M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

Against the trend, Pavadi Capital opened a new position in Medtronic worth $5.85M.

  • Pavadi Capital's largest Q4 2022 buy was Medtronic: 75,273 shares worth $5.85M.
  • Pavadi Capital added most to CVS Health in Q4 2022, an estimated $1.34M increase.
  • Pavadi Capital's biggest Q4 2022 reduction was Cardinal Health, cutting an estimated $3.3M.
  • Pavadi Capital fully exited AMN Healthcare in Q4 2022, selling an estimated $5.96M.
  • Pavadi Capital's ten largest holdings make up 63% of its $106M portfolio in Q4 2022.
  • Pavadi Capital opened 5 new positions and closed 10 in Q4 2022.
  • Pavadi Capital's portfolio value rose 1.6% quarter-over-quarter to $106M.

Based on Pavadi Capital's 13F filing for Q4 2022, filed 14 Feb 2023.